Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s share price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.74 and traded as low as $0.60. Medicure shares last traded at $0.60, with a volume of 5,000 shares.
Medicure Trading Down 7.8 %
The company has a market cap of $6.21 million, a price-to-earnings ratio of -4.25 and a beta of 0.98. The business has a fifty day simple moving average of $0.66 and a 200 day simple moving average of $0.74. The company has a quick ratio of 1.64, a current ratio of 2.03 and a debt-to-equity ratio of 0.03.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Stories
- Five stocks we like better than Medicure
- Industrial Products Stocks Investing
- Top 3 Investment Themes to Watch for in 2025
- Using the MarketBeat Dividend Tax Calculator
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
